-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...
-
Product Insights
Neurosurgical Products Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Neurosurgical Products Pipeline Market Report Overview The neurosurgical products pipeline market research report provides comprehensive information about the neurosurgical products pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Dura Substitutes ·      Neuroendoscopes ·      Neurosurgical Drills ·      Synthetic Dura Substitutes ·      Neurosurgical Drills ·      Biological Dura Substitutes Key Territories ·      The US ·      Europe ·      Canada ·      Israel ·      Japan ·      Philippines...
-
Product Insights
NewAprinoia Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Aprinoia Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Aprinoia Therapeutics Inc (Aprinoia) is a biotechnology company that provides diagnostic tools and novel therapies for the treatment of human neurological conditions. Its product pipeline includes florzolotau (18F), a PET imaging tracer; 18F-APN-1701, a PET imaging agent targeted for Alzheimer’s and Tauopathies; α-synuclein proteins for Parkinson’s disease; APNmAb005; tau modulator; degrader candidates to capture pathological tau species targeted for...
-
Product Insights
AbbVie Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our AbbVie Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. AbbVie Inc (AbbVie) is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. Its drugs are indicated for the treatment of metabolic and rheumatological diseases, neurological disorders, skin diseases, rheumatoid arthritis, pain related to endometriosis, pediatric Crohn's disease, cancer, and other serious health conditions. AbbVie is also advancing its pipeline...
-
Product Insights
NewPopulation Bio Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Population Bio Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Population Bio Inc (PB), formerly Population Diagnostics Inc is a gene discovery company that develops DNA-based diagnostics and personalized medicine tests. The company performs research, development and discovery of platform technology for validation of causative genetic biomarkers. Its RationalCNV analysis offers medical relevance to variants of unknown significance and novel variants. PB develops various therapies such as novel targeted...
-
Product Insights
NewOrion Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Orion Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer, and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson’s disease, chronic obstructive pulmonary disease, and various cancer types. Orion’s client base consists of...
-
Product Insights
NewElectroCore Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ElectroCore Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ElectroCore Inc (ElectroCore) is a bioelectronic medicine healthcare company. The company develops vagus nerve stimulation non-invasively (nVNS) therapy for neurology and rheumatology. It primarily focuses on headaches such as episodic cluster headache, migraine, and posttraumatic headache; Parkinson's disease; Subarachnoid hemorrhage; exploring acute trauma; neurodegenerative conditions, and chronic central inflammation. ElectroCore is also involved in offering treatments for respiratory distress for...
-
Product Insights
NewAxim Biotechnologies Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Axim Biotechnologies Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Axim Biotechnologies Inc (Axim Biotechnologies), is a biotechnology company. It focuses on research, development and production of pharmaceutical, nutraceutical, cosmetic products, and alternative sources of energy. The company develops pharmaceutical delivery systems and API (active pharmaceutical ingredients) for treatment of conditions such as Parkinson’s disease, Alzheimer’s disease, ADHD (attention deficit hyperactivity disorder), spasticity, pain, RLS (restless leg syndrome) and...
-
Product Insights
NewProMIS Neurosciences Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ProMIS Neurosciences Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company that focuses on the development of therapeutic antibodies and diagnostics for the treatment of neurodegenerative disorders. The companies major products include tests functional assays. The company’s PMN 310, a monoclonal antibody (mAb), designated as its first lead product for development in AD. The company...